계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Ashvattha Therapeutics
company
About
Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Convertable Note
- Last Funding Money Raised
- $22M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$29M
Ashvattha Therapeutics has raised a total of
$29M
in funding over 2 rounds. Their latest funding was raised on
May 31, 2020 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 31, 2020 | Convertable Note | $22M | 2 |
Natural Capital
|
— | Detail |
| Mar 15, 2019 | Series A | $7M | 1 |
Natural Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Ashvattha Therapeutics is funded by 2 investors.
Natural Capital
and Zephyr Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Natural Capital
|
Yes | Convertable Note |
|
|
— | Convertable Note |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
